Topoisomerase I and II activity in human breast, cervix, lung and colon cancer
W. Nicol Keith(University of Glasgow), Robert Brown(Emerson College), Fiona Douglas(University of Southern California), R.P. Symonds(Beatson West of Scotland Cancer Centre), Ate G.J. van der Zee(Target (United States)), Stanley B. Kaye(Beatson West of Scotland Cancer Centre), Drew Prakash(Hairmyres Hospital), Melanie Oates(University of Glasgow)
Cited by 81
Related Papers
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
|The American Journal of Human Genetics|2001|1.1k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772